Prelude Therapeutics Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Prelude Therapeutics Inc
Did you know?
Holds 2.2x more cash than debt — a strong balance sheet.
Current Price
$4.74
+0.85%GoodMoat Value
$0.97
79.6% overvaluedProfile
Valuation (TTM)
Market Cap$297.98M
P/E-2.99
EV—
P/B4.34
Shares Out62.87M
P/Sales24.55
Revenue$12.14M
EV/EBITDA—
PRLD (PRLD) — Earnings Call Transcripts
No transcripts available yet
No earnings call transcripts are available for PRLD yet. Check back after the next earnings report.
← Back to PRLD overview